JP2018505135A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018505135A5 JP2018505135A5 JP2017529712A JP2017529712A JP2018505135A5 JP 2018505135 A5 JP2018505135 A5 JP 2018505135A5 JP 2017529712 A JP2017529712 A JP 2017529712A JP 2017529712 A JP2017529712 A JP 2017529712A JP 2018505135 A5 JP2018505135 A5 JP 2018505135A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- acid sequence
- amino acid
- seq
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14307096 | 2014-12-19 | ||
| EP14307096.9 | 2014-12-19 | ||
| PCT/EP2015/080653 WO2016097369A1 (en) | 2014-12-19 | 2015-12-18 | Multimerization of recombinant protein by fusion to a sequence from lamprey |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018505135A JP2018505135A (ja) | 2018-02-22 |
| JP2018505135A5 true JP2018505135A5 (https=) | 2021-02-18 |
| JP6964518B2 JP6964518B2 (ja) | 2021-11-10 |
Family
ID=52345010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017529712A Active JP6964518B2 (ja) | 2014-12-19 | 2015-12-18 | ヤツメウナギ由来の配列への融合による組換えタンパク質の多量体化 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10118951B2 (https=) |
| EP (1) | EP3233924B1 (https=) |
| JP (1) | JP6964518B2 (https=) |
| CN (1) | CN107108755B (https=) |
| AU (1) | AU2015366212B2 (https=) |
| CA (1) | CA2969396A1 (https=) |
| HK (1) | HK1245809B (https=) |
| WO (1) | WO2016097369A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE1500434A1 (en) * | 2015-10-29 | 2017-04-30 | Theravac Pharmaceuticals Ab | A novel fusion partner for highly efficient and safe vaccines |
| EP3374504B1 (en) * | 2015-11-09 | 2025-03-19 | CureVac SE | Optimized nucleic acid molecules |
| KR101972894B1 (ko) * | 2017-05-18 | 2019-04-29 | 경상대학교산학협력단 | 소수성 테일 도메인이 제거된 먹장어 유래 vlrb 단백질에 칠성장어 유래 vlrb 단백질의 c 말단 서열이 연결된 융합 단백질 및 이의 용도 |
| CA3073646A1 (en) | 2017-08-21 | 2019-02-28 | Dyadic International Inc. | Production of flu vaccine in myceliophthora thermophila |
| KR102837045B1 (ko) | 2020-06-09 | 2025-07-23 | 케이엠 바이올로직스 가부시키가이샤 | 사이토메갈로바이러스의 gB와 펜타머의 융합 단백질 및 당해 융합 단백질을 포함하는 백신 |
| CN118910106A (zh) * | 2023-05-08 | 2024-11-08 | 上海岱翱生物科技有限公司 | 一种tshr融合蛋白及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2659574C (en) * | 2006-08-02 | 2017-04-25 | The Uab Research Foundation | Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity |
| US20090312249A1 (en) | 2007-12-06 | 2009-12-17 | Korea Advanced Institute Of Science And Technology | TLR4 decoy receptor protein |
| CN101830986A (zh) * | 2009-03-13 | 2010-09-15 | 北京表源生物技术有限公司 | 一种融合蛋白多聚体 |
| GB0922209D0 (en) * | 2009-12-18 | 2010-02-03 | Univ Nottingham | Proteins, nucleic acid molecules and compositions |
| US9238683B2 (en) * | 2011-02-23 | 2016-01-19 | University Of Maryland College Park | Efficient mucosal vaccination mediated by the neonatal Fc receptor |
| KR20120107741A (ko) | 2011-03-22 | 2012-10-04 | 한국생명공학연구원 | 패혈증 단백질 치료제의 효능 분석 및 스크리닝 방법 |
| CN104066751A (zh) * | 2011-11-22 | 2014-09-24 | 马里兰州大学(巴尔的摩) | 对聚糖具有高亲和力和选择性的lambody及其用途 |
| JP2016517391A (ja) * | 2013-02-15 | 2016-06-16 | ニューヨーク ブラッド センター インコーポレイテッド | オリゴマーインフルエンザ免疫原性組成物 |
-
2015
- 2015-12-18 AU AU2015366212A patent/AU2015366212B2/en active Active
- 2015-12-18 US US15/536,726 patent/US10118951B2/en active Active
- 2015-12-18 HK HK18105140.8A patent/HK1245809B/en unknown
- 2015-12-18 CN CN201580069763.4A patent/CN107108755B/zh active Active
- 2015-12-18 WO PCT/EP2015/080653 patent/WO2016097369A1/en not_active Ceased
- 2015-12-18 CA CA2969396A patent/CA2969396A1/en active Pending
- 2015-12-18 EP EP15817288.2A patent/EP3233924B1/en active Active
- 2015-12-18 JP JP2017529712A patent/JP6964518B2/ja active Active
-
2018
- 2018-09-26 US US16/143,079 patent/US10577398B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018505135A5 (https=) | ||
| CN105765063B (zh) | 应用改变的辅助噬菌体制备抗原结合分子的方法 | |
| JP2017514522A5 (https=) | ||
| JP6518193B2 (ja) | 改善された特性を有する改変コイルドコイル型タンパク質 | |
| JP2022533318A (ja) | 気道感染の治療または予防のためのサブユニットワクチン | |
| CN105246910A (zh) | 热稳定的呼吸道合胞病毒融合前f蛋白寡聚物及其在免疫组合物中的用途 | |
| JP2015509707A5 (https=) | ||
| JP2024160245A (ja) | アデノウイルスコートタンパク質由来送達賦形剤 | |
| JP2016533332A5 (https=) | ||
| JP2015212284A5 (https=) | ||
| JP2014521313A5 (https=) | ||
| JP7705672B2 (ja) | 核酸多量化を介した多価タンパク質薬物およびワクチンの構築方法と適用 | |
| US20240093159A1 (en) | Virus-like particles and methods of production thereof | |
| JP6964518B2 (ja) | ヤツメウナギ由来の配列への融合による組換えタンパク質の多量体化 | |
| JP2008524261A5 (https=) | ||
| CN110225972A (zh) | 免疫组库序列扩增方法及应用 | |
| Powell et al. | Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies | |
| Ebrahimi et al. | Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70359–610 in prokaryotic system as a fusion protein | |
| CA3235138A1 (en) | Engineering antigen binding to, and orientation on, adjuvants for enhanced humoral responses and immunofocusing | |
| CN109415410B (zh) | 靶向树突细胞的肽、利用了该肽的肽融合体、及利用了该肽融合体的疫苗 | |
| WO2004087886A3 (en) | Modified adenoviral e1a constructs and methods of use thereof | |
| JP2021533772A (ja) | フィロウイルス糖タンパク質の安定化された三量体 | |
| JP2009536821A5 (https=) | ||
| Geels et al. | Developments in high-yield system expressed vaccines and immunotherapy | |
| US11028132B1 (en) | Half-life optimized linker composition |